Evidence map›Paper›PMID 41259557›Full record

ArticleJournal of applied oral science : revista FOB2025

Monocytes and Macrophage-derived mediators influence the behavior of squamous cell carcinoma cell lines.

Graziela Perri, Raíssa Gabrieli Candido, Luiz Henrique Camargo Soares, Rafael Carneiro Ortiz, Izabel de Camargo, Maria Renata Sales Nogueira, Edgard José Franco Mello Júnior, Ana Lucia Coelho, Edwin M Posadas, Cory Hogaboam and 2 more

Abstract read
In one paragraph

Article in Journal of applied oral science : revista FOB, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Graziela PerriUniversidade de São Paulo, Faculdade de Odontologia de Bauru, Departamento de Ciências Biológicas, Bauru, SP, Brasil.ORCID http://orcid.org/0000-0002-4937-210X
Raíssa Gabrieli CandidoUniversidade de São Paulo, Faculdade de Odontologia de Bauru, Departamento de Ciências Biológicas, Bauru, SP, Brasil.ORCID http://orcid.org/0000-0002-2939-7465
Luiz Henrique Camargo SoaresUniversidade de São Paulo, Faculdade de Odontologia de Bauru, Departamento de Ciências Biológicas, Bauru, SP, Brasil.
Rafael Carneiro OrtizUniversidade de São Paulo, Faculdade de Odontologia de Bauru, Departamento de Ciências Biológicas, Bauru, SP, Brasil.ORCID http://orcid.org/0000-0002-2794-0460
Izabel de CamargoUniversidade de São Paulo, Faculdade de Odontologia de Bauru, Departamento de Ciências Biológicas, Bauru, SP, Brasil.
Maria Renata Sales NogueiraSecretaria de Estado da Saúde, Instituto Lauro de Souza Lima, Bauru, SP, Brasil.ORCID http://orcid.org/0000-0001-8647-0350
Edgard José Franco Mello JúniorSecretaria de Estado da Saúde, Instituto Lauro de Souza Lima, Bauru, SP, Brasil.
Ana Lucia CoelhoCedars-Sinai Medical Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-5087-6842
Edwin M PosadasCedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.
Cory HogaboamCedars-Sinai Medical Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Los Angeles, CA, USA.
Karen A CavassaniCedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.
Ana Paula CampanelliUniversidade de São Paulo, Faculdade de Odontologia de Bauru, Departamento de Ciências Biológicas, Bauru, SP, Brasil.ORCID http://orcid.org/0000-0002-0536-5469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune cells play diverse roles in cancer development. Myeloid cells are key drivers of tumor-escape mechanisms as they suppress immune responses, facilitate metastasis, and contribute to therapy resistance. In particular, macrophages can be polarized into an inflammatory M1 (anti-tumor) or anti-inflammatory M2 (pro-tumor) phenotype. M2 macrophages are associated with tumor progression, as they secrete factors that promote tumor angiogenesis, suppress T-cell activity, and correlate with poor clinical outcomes in squamous cell carcinoma (SCC). Given this context, this study aims to demonstrate the biological effects of monocytes and both M1 and M2 macrophages in squamous cell carcinoma. Our data indicate higher CD163 immunoreactivity in biopsies from SCC patients. Furthermore, we found that a conditioned medium (CM) containing bioactive compound generated by M2 macrophages enhances the proliferation and invasion of the SCC-25 cell line in vitro. Surprisingly, CM derived from blood CD14+ monocytes increased SCC-25 proliferation at the same rate of M2 macrophages-CM. M1 macrophages conditioned medium significantly enhanced the motility and decreased proliferation in Detroit 562 cells. The analysis of tumor-associated transcripts showed that both M1 and M2 conditioned medium induced high levels of EPCAM mRNA and significantly decreased the expression of MYC, an epithelial-to-mesenchymal transition marker, in SCC cell lines. Detroit cells exposed to conditioned medium from monocytes and macrophage also showed elevated SOX2 mRNA levels. The findings suggest that monocytes and macrophage mediators exert distinct biological effects on SCC cell lines.

Indexed as

Carcinoma, Squamous CellMacrophagesMonocytesAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCell Line, TumorCell MovementCell ProliferationCulture Media, ConditionedHumansPhenotypeReceptors, Cell SurfaceReference ValuesAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCulture Media, ConditionedReceptors, Cell Surface

Identifiers

PMID41259557
PMCPMC12672000

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.